Form 4 for PBYI PUMA BIOTECHNOLOGY, INC.
Accepted 2021-11-03 00:00:00 ET · period of report 2021-11-02 · accession 0001209191-21-062777 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-03 | 2021-11-02 | PBYI | AUERBACH ALAN H | Pres AND CEO, Dir, 10% | S - Sale | $5.63 | -1,795 | 4.41M | -0.0% | -$10.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-02 | S | D | 1,795 | $5.63 | 4,414,137 | D | — | — |